Constellation Energy buying 44% stake in NRG nuclear power station for nearly $1.8 bln
Constellation Energy Corp. (CEG) said Thursday it agreed to pay $1.75 billion for 44% ownership of the South Texas Project Electric Generating Station near Houston. The seller is NRG Energy Inc. (NRG). Constellation said the 2.645 megawatt, duel-nuclear power station has the potential to run for at least 46 more years. "We look forward to working with the South Texas Project's other owners to continue bringing clean, reliable electricity to this growing region for decades to come," said Constellation Energy CEO Joe Dominguez. BofA Securities is exclusive financial adviser to Constellation on the deal, with Barclays Capital and Morgan Stanley advising NRG. For its part, NRG said it expects the sale to be leverage-neutral with net cash proceeds to be used primarily for share repurchases, as well as $500 million for deleveraging. NRG stock is up 2% in pre-market trades Thursday, while Constellation Energy rose 0.7% in aftermarket trades late Wednesday.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-01-23 0712ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom